Cargando…

Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation

BACKGROUND: Major concerns about the safety of pretransplant amiodarone use have been raised. As a result of its long half-life, the cardiac allograft is exposed to amiodarone posing potential risks such as bradycardia, requirement for pacemaker implantation, or increased mortality after heart trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivinius, Rasmus, Helmschrott, Matthias, Ruhparwar, Arjang, Darche, Fabrice F, Thomas, Dierk, Bruckner, Tom, Katus, Hugo A, Doesch, Andreas O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484508/ https://www.ncbi.nlm.nih.gov/pubmed/28684901 http://dx.doi.org/10.2147/DDDT.S136948

Ejemplares similares

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality
por: Rivinius, Rasmus, et al.
Publicado: (2017)

COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival
por: Rivinius, Rasmus, et al.
Publicado: (2018)

The influence of surgical technique on early posttransplant atrial fibrillation – comparison of biatrial, bicaval, and total orthotopic heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2017)

Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post‐transplant mortality
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2016)

Elevated pre‐transplant pulmonary vascular resistance is associated with early post‐transplant atrial fibrillation and mortality
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2021)

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
por: Rivinius, Rasmus, et al.
Publicado: (2014)

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
por: Helmschrott, Matthias, et al.
Publicado: (2017)

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
por: Helmschrott, Matthias, et al.
Publicado: (2015)

Atrial fibrillation before heart transplantation is a risk factor for post‐transplant atrial fibrillation and mortality
por: Darche, Fabrice F., et al.
Publicado: (2021)

Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation
por: Heil, Karsten M., et al.
Publicado: (2021)

Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survival
por: Rahm, Ann‐Kathrin, et al.
Publicado: (2021)

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
por: Helmschrott, Matthias, et al.
Publicado: (2014)

Frequency, Risk Factors, and Clinical Outcomes of Late-Onset Atrial Flutter in Patients after Heart Transplantation
por: Rahm, Ann-Kathrin, et al.
Publicado: (2022)

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation
por: Kraeuter, Maximilian, et al.
Publicado: (2013)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
por: Darche, Fabrice F., et al.
Publicado: (2023)

Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart Transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2022)

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation
por: Gueler, Ibrahim, et al.
Publicado: (2013)

In vivo cardiac pacemaker function of differentiated human mesenchymal stem cells from adipose tissue transplanted into porcine hearts
por: Darche, Fabrice F, et al.
Publicado: (2020)

Constrictive Pericarditis in the Presence of Remaining Remnants of a Left Ventricular Assist Device in a Heart Transplanted Patient
por: Rivinius, R., et al.
Publicado: (2015)

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
por: Doesch, Andreas O, et al.
Publicado: (2013)

Quantitative Efficacy and Fate of Mesenchymal Stromal Cells Targeted to Cardiac Sites by Radiofrequency Catheter Ablation
por: Malik, Rizwan, et al.
Publicado: (2020)

Comparative accuracy of NT‐proBNP and MR‐proANP for the diagnosis of acute heart failure in dyspnoeic patients
por: Darche, Fabrice F., et al.
Publicado: (2017)

Low-Level Elevations of Procalcitonin Are Associated with Increased Mortality in Acute Heart Failure Patients, Independent of Concomitant Infection
por: Darche, Fabrice F., et al.
Publicado: (2021)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
por: Doesch, Andreas O, et al.
Publicado: (2012)

Surgical ventricular reconstruction for the treatment of advanced heart failure—return of the surgeons?
por: Rivinius, Rasmus, et al.
Publicado: (2023)

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study
por: Doesch, Andreas O, et al.
Publicado: (2013)

Wound Infections in Adult Patients after Berlin Heart(®) EXCOR Biventricular Assist Device Implantation
por: Kremer, Jamila, et al.
Publicado: (2022)

Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells
por: Schweizer, Patrick A., et al.
Publicado: (2017)

Haemodynamic effects of percutaneous mitral valve edge‐to‐edge repair in patients with end‐stage heart failure awaiting heart transplantation
por: Geis, Nicolas A., et al.
Publicado: (2018)

The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high‐risk patients
por: Kreusser, Michael M., et al.
Publicado: (2018)

Pulmonary Function Testing Pre–heart Transplant Predicts Posttransplant Survival
por: Lundgren, Scott W., et al.
Publicado: (2021)

Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols
por: Darche, Fabrice F., et al.
Publicado: (2022)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
por: Mangan, Brendan L., et al.
Publicado: (2020)

Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review
por: Cehic, Matthew G., et al.
Publicado: (2018)

Posttransplant Complications and Genetic Loci Involved in Telomere Maintenance in Heart Transplant Patients
por: Dlouha, Dana, et al.
Publicado: (2022)

Cryoballoon pulmonary vein isolation-mediated rise of sinus rate in patients with paroxysmal atrial fibrillation
por: Wagner, Lara, et al.
Publicado: (2020)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
por: Neuringer, Isabel P.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9orjsumgld0fvk9u77o607mi2f